Cargando…

Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis

Background: Patients with venous thromboembolism have high risk of recurrence after discontinuation of anticoagulant treatment. Extended anticoagulation, such as traditional anticoagulants, can reduce the risk of recurrence but is associated with increased risk of hemorrhage. Sulodexide is a natural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Qing-Jun, Bai, Jun, Jin, Jie, Shi, Jian, Qu, Lefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092709/ https://www.ncbi.nlm.nih.gov/pubmed/30135652 http://dx.doi.org/10.3389/fphar.2018.00876

Ejemplares similares

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Andreozzi, Giuseppe M., et al.
Publicado: (2015)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
por: Pompilio, Giuseppe, et al.
Publicado: (2020)

Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
por: Li, Dandan, et al.
Publicado: (2022)

Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis
por: Bignamini, Angelo A., et al.
Publicado: (2020)

A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019
por: Liu, Yandong, et al.
Publicado: (2021)

Treatment and secondary prevention of venous thromboembolism in cancer
por: Coleman, R, et al.
Publicado: (2010)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis
por: Zhang, Juqi, et al.
Publicado: (2023)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis
por: Yi, Yi-hu, et al.
Publicado: (2022)

Sulodexide in IgA nephropathy
Publicado: (2013)

Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021)

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
por: Palareti, Gualtiero
Publicado: (2012)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China
por: Sun, Ke-Xin, et al.
Publicado: (2021)

Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China
por: Chen, Yue, et al.
Publicado: (2022)

Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life
por: Elleuch, Nizar, et al.
Publicado: (2016)

Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011)

Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer: A meta-analysis
por: Xing, Jiali, et al.
Publicado: (2018)

Secondary Polycythemia and the Risk of Venous Thromboembolism
por: Bhatt, Vijaya Raj
Publicado: (2014)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism
por: Damle, Bharat, et al.
Publicado: (2020)

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
por: Delluc, Aurélien, et al.
Publicado: (2020)

The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs
por: Serra, Raffaele, et al.
Publicado: (2014)

Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1
por: Kaczmarek, Barbara, et al.
Publicado: (2023)

Use of sulodexide in patients with peripheral vascular disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2010)

Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021)

Prevention and treatment of venous thromboembolism
por: Casadei, Barbara, et al.
Publicado: (2020)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review
por: Li, Rui, et al.
Publicado: (2015)

Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
por: Liu, Yandong, et al.
Publicado: (2019)

Arterial and venous thromboembolism risk associated with blood eosinophils: A systematic review and meta‐analysis
por: Xu, Wei‐Jie, et al.
Publicado: (2022)

Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2023)

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
por: Drago, Filippo, et al.
Publicado: (2020)

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
por: Castellucci, Lana A, et al.
Publicado: (2013)

Sulodexide Prevents Hyperglycemia-Induced Endothelial Dysfunction and Oxidative Stress in Porcine Retinal Arterioles
por: Dauth, Alice, et al.
Publicado: (2023)

Principal Component Analysis on Recurrent Venous Thromboembolism
por: Martins, Tiago D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9aaugc2ule284vm01kqdva9k6p